Literature DB >> 3142333

The use of serum transferrin in the evaluation of protein-calorie malnutrition in cancer patients.

K Thean1, S L Yo, R Nambiar, P H Lim, I K Tan.   

Abstract

Forty-five patients with various malignancies of the gastrointestinal tract had their nutritional status assessed pre-operatively to determine the prevalence of malnutrition and to establish the correlation of malnutrition with post-operative outcome. Ten nutritional parameters were assessed. Based on these markers, we found a significant degree of malnutrition. Half of the study population developed some form of post-operative complication and nearly one quarter died. Of the ten nutritional markers studied, only serum transferrin had predictive value in determining post-operative outcome. The mean level of serum transferrin for patients with major complications was 162.0 mg/dl as compared with 221.2 mg/dl for those with none or minor complications. Patients with a serum transferrin level below the reference range of 200 mg/dl had most of the major life threatening complications and deaths. The other nutritional markers studied did not correlate well with post-operative outcome. We feel that serum transferrin is a useful nutritional marker to predict post-operative outcome and also to monitor the effect of nutritional support. However, based on a preliminary study, nutritional support may be required for periods longer than two weeks to show significant improvement in protein-calorie malnutrition. We will consider giving adequate support for a longer period on a further study using serum transferrin as a marker to determine its value in monitoring any reversal of malnutrition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142333

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  2 in total

1.  Evaluation of Nutritional Status of Colorectal Cancer Patients from Algerian East Using Anthropometric Measurements and Laboratory Assessment.

Authors:  Samira Negrichi; Salima Taleb
Journal:  Iran J Public Health       Date:  2020-07       Impact factor: 1.429

2.  A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.

Authors:  S Downer; S Joel; A Allbright; H Plant; L Stubbs; D Talbot; M Slevin
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.